Mark Stephens is a seasoned professional in the managed markets sector, currently serving as the Director of Managed Markets at BridgeBio since 2024. Previously, they held the position of Corporate Account Director at Luye Pharma USA Ltd. in 2023 and worked as a Senior Strategic Account Executive at Global Blood Therapeutics from 2021 to 2022. From 1992 to 2017, they contributed to Pfizer as an Account Director for Specialty products, engaging with major Health Plans and State Medicaid across several states. Mark is actively pursuing a BS in Business Administration with a minor in Accounting at The Citadel.
This person is not in the org chart
This person is not in any teams
This person is not in any offices